- Dietze B, Rath A, Wendt C, et al. Survival of MRSA on sterile goods packaging. J Hosp Infect 2001;
49(4):255–261. - Embil J, McLeod J, Al-Barrak AM, et al. An outbreak of the methicillin-resistantStaphylococcus
aureuson a burn unit: potential role of contaminated hydrotherapy equipment. Burn 2001;27(7):
681–688. - Rampling A, Wiseman S, Davis L, et al. Evidence that hospital hygiene is important in the control of
methicillin resistantStaphylococcus aureus. J Hosp Infect 2001;49(2):109–116. - Farr BM. Prevention and control of methicillin-resistantStaphylococcus aureusinfections. Curr Opin
Infect Dis 2004;17(8):317–322. - Arnold MS, Dempsey JM, Fishman M, et al. The best hospital practices for controlling methicillin-
resistantStaphylococcus aureus: on the cutting edge. Infect Control Hosp Epidemiol 2002;23(2):69–76. - Boyce JM. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect 2001;
48(suppl A):S9–S14. - Watanakunakorn C, Axelson C, Bota B, et al. Mupirocin ointment with and without chlorhexidine
baths in the eradication ofStaphylococcus aureusnasal carriage in nursing home residents. Am J Infect
Control 1995;23(5):306–309. - Vivoni AM, Santos KRN, de-Oliveira MP, et al. Mupirocin for controlling methicillin-resistant
Staphylococcus aureus: lessons from a decade of use at a university hospital. Infect Control Hosp
Epidemiol 2005;26(7):662–667. - Silvestri L, Milanese M, Oblach L, et al. Enteral vancomycin to control methicillin-resistantStaphylococcus
aureusoutbreak in mechanically ventilated patients. Am J Infect Control 2002;30(7):391–399. - Thorburn K, Taylor N, Saladi SM, et al. Use of surveillance cultures and enteral vancomycin to
control methicillin-resistantStaphylococcus aureusin a paediatric intensive care unit. Clin Microbiol
Infect 2006;12(1):35–42. - Sandri AM, Dalarosa MG, de Alcaˆntara LR, et al. Reduction in incidence of nosocomial methicillin-
resistantStaphylococcus aureus(MRSA) infection in an intensive care unit: role of treatment with
mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp
Epidemiol 2006;27(2):185–187. - Gould IM, MacKenzie FM, MacLennan G, et al. Topical antimicrobials in combination with
admission screening and barrier precautions to control endemic methicillin-resistantStaphylococcus
aureusin an intensive care unit. Int J Antimicrob Agents 2007;29(5):536–543. - Regev-Yochay G, Rubinstein E, Barzilai A, et al. Methicillin-resistant Staphylococcus aureusin
neonatal intensive care unit. Emerg Infect Dis 2005;11(3):453–456. - Khoury J, Jones M, Grim A, et al. Eradication of methicillin-resistantStaphylococcus aureusfrom a
neonatal intensive care unit by active surveillance and aggressive infection control measures. Infect
Control Hosp Epidemiol 2005;26(7):616–621. - Doebbeling BN, Breneman DL, Neu HC, et al. Elimination ofStaphylococcus aureusnasal carriage in
healthcare workers: analysis of six clinical trials with calcium mupirocin ointment. Clin Infect Dis
1993;17(9):466–474. - Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincidentStaphylococcus aureusnasal
and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med
1991;114(2):101–106. - Chenoweth CE. Enterococcus species. In: Mayhall CG, ed. Hospital Epidemiology and Infection
Control. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2004:529–544. - Bugg TDH, Dutka-Malen S, Arthur M, et al. Identification of vancomycin resistance protein VanA as
a D-Alanine: D-Alanine ligase of altered substrate specificity. Biochemistry 1991;30(8):2017–2021. - Willems RJL, Homan W, Top J, et al. Variantespgene as a marker of a distinct genetic lineage of
vancomycin-resistantEnterococcus faeciumspreading in hospitals. Lancet 2001;357(9259):853–855. - Rice LB, Carias L, Rudin S, et al. A potential virulence gene,hylEfm, predominates inEnterococcus
faeciumof clinical origin. J Infect Dis 2003;187(3):508–512. - Shay DK, Maloney SA, Monetcalvo M, et al. Epidemiology and mortality risk of vancomycin-
resistant enterococcal bloodstream infections. J Infect Dis 1995;172(10):993–1000. - Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant
enterococci. Arch Intern Med 1996;156(13):1458–1462. - Stroud L, Edwards J, Danzig l, et al. Risk factors for mortality associated with enterococcal
bloodstream infections. Infect Control Hosp Epidemiol 1996;17(9):576–580. - Edmond MB, Ober JF, Dawson JD, et al. Vancomycin-resistant enterococcal bacteremia: natural
history and attributable mortality. Clin Infect Dis 1996;23(12):1234–1239. - Stosor V, Peterson LR, Postelnick M, et al.Enterococcus faeciumbacteremia. Does vancomycin
resistance make a difference? Arch Intern Med 1998;158(5):522–527.
124 Mayhall